secwatch.observer — SEC 8-K summary
======================================

Issuer:     COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK:        0001267565
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001104659-23-088079
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Collegium enters $50M accelerated share repurchase under $100M buyback program
------------------------------------------------------------------------------

- $50 million ASR agreement with Jefferies LLC; initial delivery of ~1.7M shares (80% of expected) based on $23.49 close
- Final settlement expected in Q4 2023 based on volume-weighted average price during term
- Part of $100M share repurchase program authorized by Board in January 2023
- As of June 30, 2023, approximately 34.7 million shares outstanding

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/0001104659-23-088079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1267565/000110465923088079/tm2323003d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-088079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer